Details van artikel 89 van 1866 gevonden artikelen
CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib
Titel:
CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib
Auteur:
Desai, J. Wagner, AJ. Carrasco, Garcia I. Cesari, M. Gordon, M. Lin, CC. Papai, Z. Ryan, CW. Tap, WD. Trent, JC. Gelderblom, H. Grimison, P. López, Pousa A. Tine, Van. Dai, D. Rubinacci, M. Tecson, K. Wooddell, M. Stacchiotti, S.
Verschenen in:
Value in health
Paginering:
Jaargang 27 () nr. 6S pagina's S20
Jaar:
2024
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 89 van 1866 gevonden artikelen